Zomedica (ZOMDF) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Customers, else..
 
Zomedica Corp   (NONE: ZOMDF)
 

Zomedica Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZOMDF Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 32.42 % 13.2 % 8.93 % 10.9 %
Q / Q Revenue Growth (Q1 MRQ) -18.98 % -2.93 % -5.89 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 21.84 % 9.56 % 8.63 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) 6.64 % 2.84 % 2 % 2.61 %
Revenue 5 Year Average Growth - 8.75 % 9.34 % 13.48 %


ZOMDF's Growth Comparisons in I. Quarter 2026




With 32.42% year on year Revenue increase in the first quarter 2026, Zomedica outperformed the 13.2% rise in the Major Pharmaceutical Preparations industry, and 8.93% growth in the Healthcare sector. Comparing the first quarter sales growth, both Major Pharmaceutical Preparations industry and Zomedica Corp outperformed 10.9% overall market increase.

Comparing company's Revenue to the fourth quarter results, sales were lower by -18.98% . On the annual basis, average annual sales growth for Zomedica is %, while S & P 500's including only Businesses with the first quarter 2026 results, average yearly sales growth is 13.48% over the past five years.

ZOMDF Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Capital
0.92 %
-
Consumables
21.64 %
-
Engineering
-
-
Other
136.17 %
-
Diagnostics
72.81 %
-
Diagnostics Capital
7.05 %
-
Diagnostics Consumables
98.26 %
-
Therapeutic Devices
-2.02 %
-
Therapeutic Devices Capital
-20.39 %
-
Therapeutic Devices Consumables
6.72 %
-
Therapeutic Devices Other
-59.57 %
-
Development Services
-
-
Development Services Capital
-
-
Development Services Consumables
-
-
Development Services Engineering
-
-
Development Services Other
-
-
US
46.11 %
-
Foreign countries
-2.14 %
-
Total
32.42 %
-73.22 %


Growth Rates of ZOMDF's Income in the first quarter 2026


ZOMDF Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - -8.88 % 4.02 % 97.6 %
Sequential Operating Income Change (Q1 MRQ) - -4.51 % 0.66 % 48.13 %
Y / Y Operating Income Growth (Q1 TTM) - 31.15 % 31.43 % 40.67 %
Sequential Operating Income Growth (Q1 TTM) - -2.06 % 4.76 % 20.86 %
Operating Income 5 Year Avg. Change - 14.98 % 10.62 % 28.66 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) - -34.9 % -27.62 % 90.69 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) - -2.6 % -67.31 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - 6.72 % 2.62 % 57.33 %
Sequential Income from Cont. Ops. Change (Q1 TTM) - -9.75 % -5.23 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - 14.8 % 8.95 % -24.17 %

ZOMDF Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) - -35.09 % -27.58 % 90.69 %
Q / Q Net Income Growth (Q1 MRQ) - 2.88 % -2.02 % 27.07 %
Y / Y Net Income Change (Q1 TTM) - 5.24 % 16.13 % 57.33 %
Sequential Net Income Change (Q1 TTM) - -9.87 % -7.05 % 18.65 %
Net Income 5 Year Avg. Growth - 14.99 % 9.41 % 30.75 %

ZOMDF's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) - -40.26 % -27.62 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) - -7.71 % -67.31 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) - - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - 2.03 % 8.95 % -24.17 %



ZOMDF EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) - -40.44 % -27.58 % -24.17 %
Q / Q EPS Net Growth (Q1 MRQ) - -2.51 % -2.02 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) - - - 4.93 %
EPS Net 5 Year Avg. Change - 14.99 % 9.41 % 30.75 %



Zomedica reported bottom-line of $ 0.00 in the first quarter, compare to $ -0.07 in the same quarter a year ago. Major Pharmaceutical Preparations industry fell by -40.44%, while Healthcare sector decreased by -27.58%, and overall market improved by 90.69%.

Comparing the company's EPS to the fourth quarter results, income per share were lower by -18.98% . On the annual basis, average annual income per share growth for Zomedica is %, while S & P 500's including only Businesses with the first quarter 2026 financial reports, average yearly income per share growth is 30.75% over the past five years.

ZOMDF Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - 25.56 % 56.3 % 48.62 %
Sequential Free Cash Flow Change (Q1 MRQ) - -43.31 % -48.97 % 34.18 %
Y / Y Free Cash Flow Change (Q1 TTM) - 13.44 % 19.54 % 60.27 %
Sequential Free Cash Flow Change (Q1 TTM) - 4.56 % 5.42 % 15.75 %
Free Cash Flow 5 Year Avg. Change - 3.5 % 1.82 % 18.38 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) -79.24 % - - 339.02 %
Sequential Net Cash Flow Change (Q1 MRQ) -76.45 % - - 216.68 %
Y / Y Net Cash Flow Change (Q1 TTM) - - - 209.43 %
Sequential Net Cash Flow Change (Q1 TTM) - - -79.52 % 152.64 %
Net Cash Flow 5 Year Avg. Change - 29.18 % 6.07 % 4.29 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) 28.25 % 11.16 % 8.3 % 120.03 %
Sequential Capital Expenditures Change (Q1 MRQ) 174.33 % -22.14 % -22.29 % 36.87 %
Y / Y Capital Expenditures Change (Q1 TTM) -73.62 % 16.93 % 8.65 % 109.38 %
Sequential Capital Expenditures Change (Q1 TTM) 9.73 % 3.01 % 2.6 % 23.05 %
Capital Expenditures 5 Year Avg. Change - 7.04 % 7.16 % 10.79 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.